Complement 1 Secures $16M for Clinically Validated Cancer Lifestyle Modification Platform
What You Should Know:
– Complement 1, a health technology startup pioneering personalized lifestyle medicine for cancer care, has announced a $16 million oversubscribed seed funding round led by Owl Ventures and Blume Ventures.
– Emerging from stealth, the company is…
Continue Reading